Astri Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 10,863 | 9,553 | 8,042 | 6,747 | 6,682 |
Operating Income | -10,863 | -9,553 | -8,042 | -6,747 | -6,682 |
Other Income | 1 | 45 | 90 | 137 | 168 |
Pre-tax Income | -10,862 | -9,508 | -7,952 | -6,610 | -6,514 |
Net Income Continuous | -10,862 | -9,508 | -7,952 | -6,610 | -6,514 |
Net Income | $-10,862 | $-9,508 | $-7,952 | $-6,610 | $-6,514 |
EPS Basic Total Ops | -3.36 | -3.18 | -3.00 | -3.30 | -3.36 |
EPS Basic Continuous Ops | -3.36 | -3.17 | -3.00 | -3.26 | -3.36 |
EPS Diluted Total Ops | -3.36 | -3.18 | -3.00 | -3.30 | -3.36 |
EPS Diluted Continuous Ops | -3.36 | -3.17 | -3.00 | -3.26 | -3.36 |
EBITDA(a) | $-10,863 | $-9,553 | $-8,042 | $-6,747 | $-6,682 |